ŠÖ“Œ˜A�‡ŽY‰È•w�l‰ÈŠw‰ï
‰ïˆõƒ�ƒOƒCƒ“ ‘ã•\ˆ¥ŽA
‘�‰ï�EŠw�p�W‰ï
‹³ˆçŠˆ“®�Ü
Šw‰ïŽ�
’芼
Œö��
—˜‰v‘Š”½
–ðˆõ�\�¬
Ž––±‹ÇˆÄ“à
‹��lŽ{�݈ꗗ
ŠÖ˜AƒŠƒ“ƒN

�@ŠÖ“Œ˜A�‡ŽY‰È•w�l‰ÈŠw‰ï‰ïŽ� ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ�[ƒiƒ‹

<< Šw‰ïŽ�‚Ö–ß‚é
<< ‘O‚̃y�[ƒW‚Ö–ß‚é

�y“Á�W�z
—‘‘ƒ�¬�n”X–E�«ŠïŒ`Žî‚Ì�Ä”­‚ÉŠÖ‚·‚錟“¢


“¡–{�@–ƒ—t, Œ´“c�@”ü—R‹I, •½’r�@�C, “¡–{�@�W‹v, ‘å�{‰ê�@�õ, “¡ˆä�@’m�s, –î–ì�@“N, �ã�È�@Žu˜Y
“Œ‹ž‘åŠwŽY‰È•w�l‰È


Key words�FMature cystic teratoma, Ovary, Recurrence, Risk factor

ŠÖ“Œ˜A�‡ŽY‰È•w�l‰ÈŠw‰ïŽ�, 49(4) 679-682, 2012


ˆê”ÊŽÐ’c–@�lŠÖ“Œ˜A�‡ŽY‰È•w�l‰ÈŠw‰ïŽ––±‹Ç�@�§102-0083 “Œ‹ž“s�ç‘ã“c‹æ��’¬4-7-7 ��’¬ƒp�[ƒNƒTƒCƒhƒrƒ‹402 Š”)MAƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒRƒ“ƒTƒ‹ƒeƒBƒ“ƒO“à
TEL�F03-3288-0993�@FAX�F03-5275-1192�@E-mail�Fkantorengo@jsog-k.jp
Copyright (C) ˆê”ÊŽÐ’c–@�lŠÖ“Œ˜A�‡ŽY‰È•w�l‰ÈŠw‰ï